{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:30:09Z","timestamp":1791433809806,"version":"4.3.3"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R43AI140941-01"],"award-info":[{"award-number":["1R43AI140941-01"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272200800039C"],"award-info":[{"award-number":["HHSN272200800039C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["HHSN272201400053C"],"award-info":[{"award-number":["HHSN272201400053C"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1S10OD011925-01"],"award-info":[{"award-number":["1S10OD011925-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1TL1TR001858"],"award-info":[{"award-number":["1TL1TR001858"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5T32AI089443-07"],"award-info":[{"award-number":["5T32AI089443-07"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.01673","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T05:08:53Z","timestamp":1595999333000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":60,"title":["Prefusion RSV F Immunization Elicits Th2-Mediated Lung Pathology in Mice When Formulated With a Th2 (but Not a Th1\/Th2-Balanced) Adjuvant Despite Complete Viral Protection"],"prefix":"10.3389","volume":"11","author":[{"given":"Katherine M.","family":"Eichinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Kosanovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonal V.","family":"Gidwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Zomback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline A.","family":"Lipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy N.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim D.","family":"Oury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolai","family":"Petrovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Yondola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry M.","family":"Empey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1128\/JVI.01625-07","article-title":"Viral and host factors in human respiratory syncytial virus pathogenesis","volume":"82","author":"Collins","year":"2008","journal-title":"J Virol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"e341","DOI":"10.1542\/peds.2013-0303","article-title":"Respiratory Syncytial Virus\u2013associated hospitalizations among children less than 24 months of age","volume":"132","author":"Hall","year":"2013","journal-title":"Pediatrics."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(10)60206-1","article-title":"Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis","volume":"375","author":"Nair","year":"2010","journal-title":"Lancet."},{"key":"B4","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/S0140-6736(17)30938-8","article-title":"Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study","volume":"390","author":"Shi","year":"2017","journal-title":"Lancet."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz683","article-title":"Cost of Respiratory Syncytial Virus-associated acute lower respiratory infection management in young children at the regional and global level: a systematic review and meta-analysis","author":"Zhang","year":"2020","journal-title":"J Infect Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1056\/NEJMoa043951","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"352","author":"Falsey","year":"2005","journal-title":"N Engl J Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/j.1532-5415.1992.tb01929.x","article-title":"Viral respiratory infections in the institutionalized elderly: clinical and epidemiologic findings","volume":"40","author":"Falsey","year":"1992","journal-title":"J Am Geriatr Soc."},{"key":"B8","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1056\/NEJM198607103150201","article-title":"Respiratory syncytial viral infection in children with compromised immune function","volume":"315","author":"Hall","year":"1986","journal-title":"N Engl J Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e00447","DOI":"10.1128\/mSphere.00447-19","article-title":"Serological array-in-well multiplex assay reveals a high rate of respiratory virus infections and reinfections in young children","volume":"4","author":"Kazakova","year":"2019","journal-title":"mSphere."},{"key":"B10","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1055\/s-0031-1283282","article-title":"Respiratory syncytial virus infection in adults","volume":"32","author":"Walsh","year":"2011","journal-title":"Semin Respir Crit Care Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1126\/science.1243283","article-title":"Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus","volume":"342","author":"McLellan","year":"2013","journal-title":"Science."},{"key":"B12","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/S0022-3476(81)80829-3","article-title":"Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level","volume":"98","author":"Glezen","year":"1981","journal-title":"J Pediatr."},{"key":"B13","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1016\/S0264-410X(03)00355-4","article-title":"Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies","volume":"21","author":"Piedra","year":"2003","journal-title":"Vaccine."},{"key":"B14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.tips.2017.06.002","article-title":"An overview of novel adjuvants designed for improving vaccine efficacy","volume":"38","author":"Bonam","year":"2017","journal-title":"Trends Pharmacol Sci."},{"key":"B15","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1016\/j.vaccine.2019.04.055","article-title":"Vaccine adjuvants: understanding the structure and mechanism of adjuvanticity","volume":"37","author":"Shi","year":"2019","journal-title":"Vaccine."},{"key":"B16","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0139916","DOI":"10.1371\/journal.pone.0139916","article-title":"Alum adjuvant enhances protection against respiratory syncytial virus but exacerbates pulmonary inflammation by modulating multiple innate and adaptive immune cells","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS ONE."},{"key":"B18","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1084\/jem.20020781","article-title":"A role for immune complexes in enhanced respiratory syncytial virus disease","volume":"196","author":"Polack","year":"2002","journal-title":"J Exp Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nm.1894","article-title":"Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease","volume":"15","author":"Delgado","year":"2009","journal-title":"Nat Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"34108","DOI":"10.1038\/srep34108","article-title":"Pre-fusion F is absent on the surface of formalin-inactivated respiratory syncytial virus","volume":"6","author":"Killikelly","year":"2016","journal-title":"Sci Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"e02180","DOI":"10.1128\/JVI.02180-16","article-title":"Immunization with low doses of recombinant postfusion or prefusion Respiratory Syncytial Virus F primes for vaccine-enhanced disease in the cotton rat model independently of the presence of a Th1-biasing (GLA-SE) or Th2-biasing (Alum) adjuvant","volume":"91","author":"Schneider-Ohrum","year":"2017","journal-title":"J Virol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"455","DOI":"10.15585\/mmwr.mm6715a5","article-title":"Recommendations of the advisory committee on immunization practices for use of a hepatitis B vaccine with a novel adjuvant","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Morb Mortal Week Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1080\/21645515.2016.1162931","article-title":"Delta inulin-derived adjuvants that elicit Th1 phenotype following vaccination reduces respiratory syncytial virus lung titers without a reduction in lung immunopathology","volume":"12","author":"Wong","year":"2016","journal-title":"Hum Vaccin Immunother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1128\/JVI.02980-14","article-title":"Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology","volume":"89","author":"Honda-Okubo","year":"2015","journal-title":"J Virol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/jmv.1890260207","article-title":"Primary respiratory syncytial virus infection in mice","volume":"26","author":"Graham BS","year":"1988","journal-title":"J Med Virol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0040499","article-title":"Stimulation of immature lung macrophages with intranasal interferon gamma in a novel neonatal mouse model of respiratory syncytial virus infection","volume":"7","author":"Empey KM","year":"2012","journal-title":"PLoS ONE."},{"key":"B27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/ppul.23911","article-title":"Localization of the T-cell response to RSV infection is altered in infant mice","volume":"53","author":"Eichinger","year":"2018","journal-title":"Pediatr Pulmonol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12931-015-0282-7","article-title":"Alveolar macrophages support interferon gamma-mediated viral clearance in RSV-infected neonatal mice","volume":"16","author":"Eichinger","year":"2015","journal-title":"Respir Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/all.13500","article-title":"RAGE-dependent VCAM-1 expression in the lung endothelium mediates IL-33-induced allergic airway inflammation","volume":"74","author":"Perkins","year":"2019","journal-title":"Allergy."},{"key":"B30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/334255a0","article-title":"Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells","volume":"334","author":"Stevens","year":"1988","journal-title":"Nature."},{"key":"B31","doi-asserted-by":"publisher","first-page":"4395","DOI":"10.1128\/JVI.03144-12","article-title":"JE-ADVAX vaccine protection against Japanese encephalitis virus mediated by memory B cells in the absence of CD8(+) T cells and pre-exposure neutralizing antibody","volume":"87","author":"Larena","year":"2013","journal-title":"J Virol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"10324","DOI":"10.1128\/JVI.00480-13","article-title":"An inactivated cell culture Japanese Encephalitis Vaccine (JE-ADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against west nile encephalitis via cross-protective memory B cells and neutralizing antibody","volume":"87","author":"Petrovsky","year":"2013","journal-title":"J Virol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1016\/j.vaccine.2009.03.026","article-title":"TLR9 agonist, but not TLR7\/8, functions as an adjuvant to diminish FI-RSV vaccine-enhanced disease, while either agonist used as therapy during primary RSV infection increases disease severity","volume":"27","author":"Johnson","year":"2009","journal-title":"Vaccine."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e02111","DOI":"10.1128\/JVI.02111-16","article-title":"CpG in combination with an inhibitor of notch signaling suppresses formalin-inactivated respiratory syncytial virus-enhanced airway hyperresponsiveness and inflammation by inhibiting Th17 memory responses and promoting tissue-resident memory cells in lungs","volume":"91","author":"Zhang","year":"2017","journal-title":"J Virol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.3390\/cells8101165","article-title":"Dendritic cells expressing MyD88 molecule are necessary and sufficient for CpG-mediated inhibition of IgE production in vivo","volume":"8","author":"Alberca Custodio","year":"2019","journal-title":"Cells."},{"key":"B36","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/archpedi.1986.02140200053026","article-title":"Risk of primary infection and reinfection with respiratory syncytial virus","volume":"140","author":"Glezen","year":"1986","journal-title":"Am J Dis Child."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1093\/infdis\/jix489","article-title":"Prefusion F, Postfusion F, G antibodies, and disease severity in infants and young children with acute Respiratory Syncytial Virus Infection","volume":"216","author":"Capella","year":"2017","journal-title":"J Infect Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"309ra162","DOI":"10.1126\/scitranslmed.aac4241","article-title":"Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera","volume":"7","author":"Ngwuta","year":"2015","journal-title":"Sci Transl Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0186854","DOI":"10.1371\/journal.pone.0186854","article-title":"Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus","volume":"12","author":"Sastry","year":"2017","journal-title":"PLoS ONE."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1164\/rccm.201412-2256OC","article-title":"Impaired antibody-mediated protection and defective IgA B-cell memory in experimental infection of adults with Respiratory Syncytial Virus","volume":"191","author":"Habibi","year":"2015","journal-title":"Am J Respir Crit Care Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1093\/infdis\/163.4.693","article-title":"Immunity to and frequency of reinfection with respiratory syncytial virus","volume":"163","author":"Hall","year":"1991","journal-title":"J Infect Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1093\/oxfordjournals.aje.a121558","article-title":"Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex","volume":"98","author":"Parrott","year":"1973","journal-title":"Am J Epidemiol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1084\/jem.179.1.81","article-title":"Distinct types of lung disease caused by functional subsets of antiviral T cells","volume":"179","author":"Alwan","year":"1994","journal-title":"J Exp Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1365-2249.1992.tb06482.x","article-title":"CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells","volume":"88","author":"Alwan","year":"1992","journal-title":"Clin Exp Immunol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1172\/JCI115362","article-title":"Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice","volume":"88","author":"Graham BS","year":"1991","journal-title":"J Clin Invest."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1084\/jem.168.3.1163","article-title":"Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus","volume":"168","author":"Cannon","year":"1988","journal-title":"J Exp Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1002\/1521-4141(200208)32:8<2117::AID-IMMU2117>3.0.CO;2-C","article-title":"Virus clearance and immunopathology by CD8(+) T cells during infection with respiratory syncytial virus are mediated by IFN-gamma","volume":"32","author":"Ostler","year":"2002","journal-title":"Eur J Immunol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1002\/1521-4141(200209)32:9<2562::AID-IMMU2562>3.0.CO;2-4","article-title":"Pulmonary T cells induced by respiratory syncytial virus are functional and can make an important contribution to long-lived protective immunity","volume":"32","author":"Ostler","year":"2002","journal-title":"Eur J Immunol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"e1006810","DOI":"10.1371\/journal.ppat.1006810","article-title":"Memory CD8 T cells mediate severe immunopathology following respiratory syncytial virus infection","volume":"14","author":"Schmidt","year":"2018","journal-title":"PLoS Pathog."},{"key":"B50","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41385-019-0243-4","article-title":"Pre-existing neutralizing antibodies prevent CD8 T cell-mediated immunopathology following respiratory syncytial virus infection","volume":"13","author":"Schmidt","year":"2019","journal-title":"Mucosal Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"8485","DOI":"10.1128\/JVI.73.10.8485-8495.1999","article-title":"Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism","volume":"73","author":"Johnson","year":"1999","journal-title":"J Virol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1093\/infdis\/167.3.553","article-title":"A human respiratory syncytial virus (RSV) primate model of enhanced pulmonary pathology induced with a formalin-inactivated RSV vaccine but not a recombinant FG subunit vaccine","volume":"167","author":"Kakuk","year":"1993","journal-title":"J Infect Dis."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e1004757","DOI":"10.1371\/journal.ppat.1004757","article-title":"RSV vaccine-enhanced disease is orchestrated by the combined actions of distinct CD4 T cell subsets","volume":"11","author":"Knudson","year":"2015","journal-title":"PLOS Pathogens."},{"key":"B54","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1099\/0022-1317-82-12-2881","article-title":"Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine","volume":"82","author":"Prince","year":"2001","journal-title":"J Gen Virol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2852","DOI":"10.1128\/JVI.70.5.2852-2860.1996","article-title":"Respiratory synctial virus infection in BALB\/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern","volume":"70","author":"Waris","year":"1996","journal-title":"J Virol."},{"key":"B56","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3389\/fimmu.2018.00840","article-title":"Group 2 innate lymphoid cells in pulmonary immunity and tissue homeostasis","volume":"9","author":"Mindt","year":"2018","journal-title":"Front Immunol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e1005217","DOI":"10.1371\/journal.ppat.1005217","article-title":"Respiratory Syncytial Virus disease is mediated by age-variable IL-33","volume":"11","author":"Saravia","year":"2015","journal-title":"PLoS Pathog."},{"key":"B58","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.jaci.2016.01.050","article-title":"Respiratory syncytial virus infection activates IL-13\u2013producing group 2 innate lymphoid cells through thymic stromal lymphopoietin","volume":"138","author":"Stier","year":"2016","journal-title":"J Aller Clin Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.immuni.2014.06.016","article-title":"MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion","volume":"41","author":"Oliphant","year":"2014","journal-title":"Immunity."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01673\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T05:08:59Z","timestamp":1595999339000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.01673\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,29]]},"references-count":59,"alternative-id":["10.3389\/fimmu.2020.01673"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.01673","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,29]]},"article-number":"1673"}}